Ronald Barbaras
Director of Exploratory Biology, CERENIS Therapeut
Biotechnology
CLINICAL RESEARCH
France
Biography
With a PhD in biochemistry, Ronald Barbaras has over 30 years of experience in lipid metabolism, the interactions between HDL and cardiovascular disease, including the binding of lipoproteins and the synthesis of cholesterol. Ronald Barbaras was formerly Research Director and group leader for ATP synthase, HDL metabolism and immune modulation at the National Institute of Health and Medical Research (INSERM), the French public research organization dedicated to biological, medical and public health. He was at the origin of the discovery of the F1-ATPase and P2Y13 receptor in the liver as key regulators of HDL elimination by the liver. He has published over 45 papers in international peer-reviewed journals.
Research Interest
lipid metabolism
